Correlation Between Bionoid Pharma and HempAmericana

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bionoid Pharma and HempAmericana at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionoid Pharma and HempAmericana into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bionoid Pharma and HempAmericana, you can compare the effects of market volatilities on Bionoid Pharma and HempAmericana and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionoid Pharma with a short position of HempAmericana. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionoid Pharma and HempAmericana.

Diversification Opportunities for Bionoid Pharma and HempAmericana

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Bionoid and HempAmericana is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Bionoid Pharma and HempAmericana in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HempAmericana and Bionoid Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionoid Pharma are associated (or correlated) with HempAmericana. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HempAmericana has no effect on the direction of Bionoid Pharma i.e., Bionoid Pharma and HempAmericana go up and down completely randomly.

Pair Corralation between Bionoid Pharma and HempAmericana

Given the investment horizon of 90 days Bionoid Pharma is expected to under-perform the HempAmericana. But the pink sheet apears to be less risky and, when comparing its historical volatility, Bionoid Pharma is 50.44 times less risky than HempAmericana. The pink sheet trades about -0.2 of its potential returns per unit of risk. The HempAmericana is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  0.01  in HempAmericana on October 21, 2024 and sell it today you would earn a total of  0.00  from holding HempAmericana or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy90.48%
ValuesDaily Returns

Bionoid Pharma  vs.  HempAmericana

 Performance 
       Timeline  
Bionoid Pharma 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bionoid Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Bionoid Pharma reported solid returns over the last few months and may actually be approaching a breakup point.
HempAmericana 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in HempAmericana are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, HempAmericana reported solid returns over the last few months and may actually be approaching a breakup point.

Bionoid Pharma and HempAmericana Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bionoid Pharma and HempAmericana

The main advantage of trading using opposite Bionoid Pharma and HempAmericana positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionoid Pharma position performs unexpectedly, HempAmericana can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HempAmericana will offset losses from the drop in HempAmericana's long position.
The idea behind Bionoid Pharma and HempAmericana pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Transaction History
View history of all your transactions and understand their impact on performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.